Literature DB >> 24129971

MRI manifestations of liver epithelioid and nonepithelioid angiomyolipoma.

Yanfeng Zhao1, Han Ouyang, Xiaoyi Wang, Feng Ye, Jing Liang.   

Abstract

PURPOSE: To retrospectively analyze the magnetic resonance imaging (MRI) manifestations of liver AML and compare the MRI manifestations of epithelioid and nonepithelioid angiomyolipoma (AML).
MATERIALS AND METHODS: The study comprised a retrospective analysis of 11 patients whose hepatic AML was confirmed by surgical pathology. Routine MRI examination was performed in 11 patients, of which five were cases of epithelioid AML and six were cases of nonepithelioid AML. One case of nonepithelioid AML underwent a plain MRI scan only, while the remaining 10 patients underwent MRI and dynamic contrast-enhanced scans.
RESULTS: Chemical shift imaging detected more fat component cases than frequency the saturation method did (7/11 vs. 3/11). The difference was not statistically significant, however (P = 0.236). The degree of fatty component was different between epithelioid and nonepithelioid AML, but there was no significant difference between them (P = 0.766). Of the 10 cases in which enhancement scans were performed, nine had hyperenhancement in the arterial phase, and nine had capsule enhancement on delayed phase.
CONCLUSION: The amount of fat content is not related to whether the tumor is epithelioid or nonepithelioid. Under dynamic contrast-enhancement MRI, epithelioid AML shows enhancement patterns similar to those of classic AML rich in vascular smooth muscles.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  angiomyolipoma; liver; magnetic resonance

Mesh:

Substances:

Year:  2013        PMID: 24129971     DOI: 10.1002/jmri.24291

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  7 in total

1.  Primary retroperitoneal perivascular epithelioid cell neoplasm: A case report.

Authors:  Wenjie Liang; Chang Xu; Feng Chen
Journal:  Oncol Lett       Date:  2015-05-14       Impact factor: 2.967

Review 2.  Primary hepatic epithelioid angiomyolipoma: A malignant potential tumor which should be recognized.

Authors:  Jie Liu; Cheng-Wu Zhang; De-Fei Hong; Ran Tao; Yuan Chen; Min-Jie Shang; Yu-Hua Zhang
Journal:  World J Gastroenterol       Date:  2016-05-28       Impact factor: 5.742

3.  Gd-EOB-DTPA-enhanced and diffusion-weighted magnetic resonance findings in hepatic epithelioid angiomyolipoma: A case report.

Authors:  Jun Sun; Shouan Wang; Wenxin Chen; Jingtao Wu
Journal:  Oncol Lett       Date:  2015-06-11       Impact factor: 2.967

Review 4.  Improving recognition of hepatic perivascular epithelioid cell tumor: Case report and literature review.

Authors:  Toshiya Maebayashi; Katsumi Abe; Takuya Aizawa; Masakuni Sakaguchi; Naoya Ishibashi; Osamu Abe; Tadatoshi Takayama; Hisashi Nakayama; Shunichi Matsuoka; Kazushige Nirei; Hitomi Nakamura; Masahiro Ogawa; Masahiko Sugitani
Journal:  World J Gastroenterol       Date:  2015-05-07       Impact factor: 5.742

5.  Unresectable hepatic PEComa: a rare malignancy treated with stereotactic body radiation therapy (SBRT) followed by complete resection.

Authors:  Simon Kirste; Gian Kayser; Anne Zipfel; Anca-Ligia Grosu; Thomas Brunner
Journal:  Radiat Oncol       Date:  2018-02-20       Impact factor: 3.481

6.  Hepatic epithelioid angiomyolipoma with renal metastasis: radiologic-pathologic correlation.

Authors:  Adrian Marcuzzi; Ehsan A Haider; Ishaq S Al Salmi
Journal:  Radiol Case Rep       Date:  2018-06-15

7.  CT features of hepatic epithelioid angiomyolipoma: differentiation from hepatocellular carcinoma in patients with noncirrhotic livers.

Authors:  Weihai Liu; Wenjie Liang
Journal:  Quant Imaging Med Surg       Date:  2018-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.